Pre-market Hot Trades in US Stocks
Coherent Corp. is down 4.55% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 14, Coherent Corp. gained attention due to its partnership with Nvidia and its potential in the AI data center market. Bank of America raised its target price to $400, although it maintained a &#34;neutral&#34; rating. This move reflects the market's optimistic expectations for its future growth.
</li>
<li>
On May 13, Coherent Corp. was favored due to its significant share in the global transceiver market amid a surge in demand for optical modules. Analysts pointed out its advantages in the shipment growth of 800G and 1.6T transceivers.
</li>
<li>
On May 12, the long-term outlook for AI data centers drove up Coherent Corp.'s stock price. Despite facing challenges from rising short-term capital expenditures and R&amp;D costs, the long-term market outlook remains strong. The AI data center market has broad prospects, and the industry cycle continues to thrive.
</li>
</ol>
Arm is down 4.50% in pre-market trading. Based on recent news:
<ol>
<li>
On May 14, Arm Holdings and its parent company SoftBank Group attempted to acquire AI chip company Cerebras Systems but were rejected. Cerebras plans to conduct an IPO, with a valuation potentially reaching $34 billion, making it one of the largest IPOs this year. This news led to uncertainty about Arm's future growth expectations, causing its stock price to drop.
</li>
<li>
On May 14, UBS released a report indicating that Arm's market share in the server CPU market rose from 11.5% to 17.7% in the first quarter of 2026, but growth may slow due to memory and wafer supply constraints. Concerns about supply chain issues have intensified, affecting investor confidence.
</li>
<li>
On May 14, analysts noted that total PC CPU shipments in the first quarter of 2026 decreased by 13% quarter-over-quarter, below the five-year average. Although Arm's market share has increased, the overall weak performance of the PC market has negatively impacted its stock price. Tech stocks are facing adjustments, and market uncertainty is rising.
</li>
</ol>
Top Gainers in Pre-market US Stocks
HCW Biologics is up 156% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 14, HCW Biologics announced its research findings that HCW11-040 prevents bronchopulmonary dysplasia (BPD) in IND-enabled studies, with expectations to complete the research and submit an IND application in the second half of 2027. This breakthrough discovery significantly boosted the stock price. Source: Reuters
</li>
<li>
On May 14, HCW Biologics released its financial report for the first quarter of 2026, showing significant progress in the field of innovative combination immunotherapy, attracting investor attention. Source: HCW Biologics official website
On May 15, analysts gave HCW Biologics a &#34;Buy&#34; rating, with Wall Street's 12-month price target set at $2, approximately 472.4% higher than the closing price on May 13. This optimistic analyst rating further propelled the stock price upward. Source: Reuters The biotechnology industry has recently performed strongly, with significant capital inflows.
</li>
</ol>
Dreamland pre-market rose 92.50%. Based on recent news,
<ol>
<li>
On May 12, Dreamland announced that its subsidiary Trendic International signed a memorandum of understanding with LinkFung Innovation to develop and deploy a comprehensive AI-driven smart image library platform. This collaboration is expected to leverage the complementary strengths of both parties to drive market expansion and enhance profitability. Following the announcement, the stock price surged.
</li>
<li>
On May 13, Dreamland's stock price skyrocketed by 126.92%, closing at $2.36, with a trading volume of approximately $219 million. Technical indicators showed bullish signals, but considering the extreme single-day increase, market sentiment was clearly driven by speculation, with speculative funds pouring in.
</li>
<li>
On May 14, technical analysis showed that Dreamland's RSI reached 97.75, indicating that the stock price was severely overbought, posing a risk of sharp correction. The stock price was far above key moving averages, and while the market outlook was optimistic, volatility was extremely high in the short term. There have been no significant positive developments in the film and entertainment industry recently, and the market is highly speculative.
</li>
</ol>
Murano Global BV pre-market rose 64.06%. Based on recent key news:
<ol>
<li>
On May 11, Murano Global Investments' Form 3 revealed that CEO Sacal Cababie Elias holds 69,152,609 common shares, increasing market confidence in the stability of the company's leadership, which drove the stock price up.
</li>
<li>
On May 11, Murano Global Investments appointed Oscar Jazmani Mendoza Escobar as Chief Financial Officer, and the market's expectations for the new management team boosted investor confidence, leading to a rise in the stock price.
</li>
<li>
On May 11, Murano Global Investments appointed Marcos Sacal Cohen as Chief Operating Officer and Director, further solidifying the company's management team and enhancing market confidence in the company's future development, resulting in a rise in the stock price. The U.S. stock market has recently experienced increased volatility, and risks should be monitored
</li>
</ol>

COHR

Coherent Corp. pre-market down 4.55%; Arm pre-market down 4.50%; HCW Biologics pre-market up 156.05%; Dreamland pre-market up 92.50%; Murano Global BV pre-market up 64.06%

- Coherent Corp. shares fell 4.55% amid news of growing interest in its AI data center potential and an upgraded price target from BofA Securities to $400, despite a neutral rating.  
- Arm Holdings experienced a 4.50% drop following a failed acquisition of AI chip company Cerebras Systems, raising uncertainties about its growth prospects.  
- HCW Biologics surged 156% after announcing a breakthrough in research for preventing bronchopulmonary dysplasia and gaining a "buy" rating from analysts, reflecting renewed investor interest.

Price Alert

Pre-market hot trades in US stocks: Coherent Corp. down 4.55% in pre-market; Arm down 4.50% in pre-market